Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study, Journal of Patient-Reported Outcomes, January 2023, Springer Science + Business Media,
DOI: 10.1186/s41687-023-00543-5.
You can read the full text:

Read

Contributors

The following have contributed to this page